Cargando…
Evolution of CD8(+) T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer
Engineered T cell receptor T (TCR-T) cell therapy has facilitated the generation of increasingly reliable tumor antigen-specific adaptable cellular products for the treatment of human cancer. TCR-T cell therapies were initially focused on targeting shared tumor-associated peptide targets, including...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469972/ https://www.ncbi.nlm.nih.gov/pubmed/34572028 http://dx.doi.org/10.3390/cells10092379 |